CASP2 and metabolic dysfunction-associated steatohepatitis: This is consistent with recent studies uncovering a key role of caspase-2 in lipotoxicity-induced apoptosis in hepatocytes, promoting the development of non-alcoholic steatohepatitis (NASH) that evolves into hepatocellular carcinoma [45–47].